Nooka, A. K., Kaufman, J. L., Rodriguez, C., Jakubowiak, A., Efebera, Y., Reeves, B., . . . Voorhees, P. (2022). Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN. Blood Cancer Journal, 12(4), 1-5. https://doi.org/10.1038/s41408-022-00653-1

Nooka, Ajay K., et al. "Daratumumab Plus Lenalidomide/bortezomib/dexamethasone in Black Patients with Transplant-eligible Newly Diagnosed Multiple Myeloma in GRIFFIN." Blood Cancer Journal 12, no. 4 (2022): 1-5. https://doi.org/10.1038/s41408-022-00653-1.

Nooka, Ajay K., et al. "Daratumumab Plus Lenalidomide/bortezomib/dexamethasone in Black Patients with Transplant-eligible Newly Diagnosed Multiple Myeloma in GRIFFIN." Blood Cancer Journal, vol. 12, no. 4, 2022, pp. 1-5, https://doi.org/10.1038/s41408-022-00653-1.